B-cell maturation and antibody responses in individuals carrying a mutated CD19 allele

Genes and Immunity

Volumn 11, Issue 7, 2010, Pages 523-530

  Artac, H ^a   Reisli, I ^a   Kara, R ^a   Pico Knijnenburg, I ^b   Adin Cinar S ^c   Pekcan, S ^a   Jol Van Der Zijde, C M ^d   Van Tol, M J D ^d   Bakker Jonges, L E ^b   Van Dongen, J J M ^b   Van Der Burg, M ^b   Van Zelm, M C ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ISTANBUL UNIVERSITY   (Turkey)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

antibody deficiency; B cell; CD21; D19; heterozygous mutation; vaccination response

Indexed keywords

CD19 ANTIGEN; IMMUNOGLOBULIN; RABIES VACCINE; TETANUS TOXOID;

ADOLESCENT; ALLELE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CHILD; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VACCINATION;

ADULT; ANTIBODY FORMATION; ANTIGENS, CD19; BASE SEQUENCE; CELL DIFFERENTIATION; CHILD; COHORT STUDIES; CONSANGUINITY; FEMALE; HETEROZYGOTE; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MUTATION; PEDIGREE; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 77958153348     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.22     Document Type: Article

References (33)

1. Pan-Hammarstrom Q, Hammarstrom L. Antibody deficiency diseases. Eur J Immunol 2008; 38: 327-333.
2. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009; 27: 199-227.
3. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120: 776-794.
4. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268.
5. van Zelm MC, Reisli I, van der Burg M, Castaño D, van Noesel CJM, van Tol MJD et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354: 1901-1912.
6. Kanegane H, Agematsu K, Futatani T, Sira MM, Suga K, Sekiguchi T et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007; 8: 663-670.
7. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37: 820-828.
8. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37: 829-834.
9. Sekine H, Ferreira RC, Pan-Hammarstrom Q, Graham RR, Ziemba B, de Vries SS et al. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci USA 2007; 104: 7193-7198.
10. Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Bohm J et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 2009; 106: 13945-13950.
11. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010; 120: 214-222.
12. van Zelm MC, Smet J, Adams B, Mascart F, Schandene L, Janssen F et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010; 120: 1265-1274.
13. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256: 105-107.
14. Andersen P, Permin H, Andersen V, Schejbel L, Garred P, Svejgaard A et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 2005; 105: 511-517. (Pubitemid 40070729)
15. Brinkman DM, Jol-van der Zijde CM, ten Dam MM, Vossen JM, Osterhaus AD, Kroon FP et al. Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man. J Clin Immunol 2003; 23: 528-538.
16. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-1377.
17. van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 2007; 204: 645-655.
18. Cuss AK, Avery DT, Cannons JL, Yu LJ, Nichols KE, Shaw PJ et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006; 176: 1506-1516.
19. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005; 105: 4390-4398.
20. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995; 376: 352-355.
21. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 1996; 157: 4371-4378.
22. Gary-Gouy H, Bruhns P, Schmitt C, Dalloul A, Daeron M, Bismuth G. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000; 275: 548-556.
23. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
24. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112: 277-286.
25. Fieschi C, Vince N, Boutboul D, Just N, Oksenhendler E, Malphettes M. Complete CD19 deficiency in two patients previously diagnosed as common variable immunodeficiency. Clin Exp Immunol 2008; 154: 222-223.
26. Isnardi I, Ng YS, Srdanovic I, Motaghedi R, Rudchenko S, von Bernuth H et al. IRAK-4-and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008; 29: 746-757.
27. Ng YS, Wardemann H, Chelnis J, Cunningham-Rundles C, Meffre E. Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med 2004; 200: 927-934.
28. Braig DU, Schaffer AA, Glocker E, Salzer U, Warnatz K, Peter HH et al. Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity. Hum Genet 2003; 112: 369-378.
29. Finck A, Van der Meer JW, Schaffer AA, Pfannstiel J, Fieschi C, Plebani A et al. Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur J Hum Genet 2006; 14: 867-875. (Pubitemid 43923373)
30. Schaffer AA, Pfannstiel J, Webster AD, Plebani A, Hammar-strom L, Grimbacher B. Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q. Hum Genet 2006; 118: 725-729.
31. Salzer U, Neumann C, Thiel J, Woellner C, Pan-Hammarstrom Q, Lougaris V et al. Screening of functional and positional candidate genes in families with common variable immunodeficiency. BMC Immunol 2008; 9: 3.
32. Stiehm ER, Ochs HD, Winkelstein JA (eds). Immunodeficiency disorders: general considerations. Immunologic Disorders in Infants and Children. Saunders: Philadelphia, 2004, pp 289-355.
33. Tedder TF, Isaacs CM. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 1989; 143: 712-717.